new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Pfizer Inc
Pfizer Inc And Renovis Inc
Pfizer Inc Products Inc
Pfizer Inc Pfizer Products Inc
  

Pfizer Inc patents (2015 archive)

Recent patent applications related to Pfizer Inc. Pfizer Inc is listed as an Agent/Assignee. Note: Pfizer Inc may have other listings under different names/spellings. We're not affiliated with Pfizer Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Pfizer Inc-related inventors




Date Pfizer Inc patents (2015 archive) (updated weekly) - BOOKMARK this page
12/31/15N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
12/31/15Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
12/24/15Novel 4-(substituted amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors
12/17/15Substituted dihydroisoquinolinone compounds
12/10/15Quinolinyl glucagon receptor modulators
12/10/15Triazine derivatives
12/03/15Compositions and methods for counteracting factor xa inhibition
12/03/15Heteroaromatic compounds and their use as dopamine d1 ligands
12/03/15Heteroaromatic compounds and their use as dopamine d1 ligands
11/26/15Substituted acetyl-coa carboxylase inhibitors
11/26/15Antagonist antibodies against gdf-8 and uses therefor
11/26/15Anti-tofacitinib antibodies and uses thereof for drug monitoring
11/19/15Glycoconjugation process
11/19/15Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction
11/19/15Pyrazolopyridines and pyrazolopyrimidines
11/19/15Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of asgpr
11/12/15Tropomyosin-related kinase inhibitors
11/12/15Azabenzimidazole compounds
11/12/15Engineered monomeric antibody fragments
11/05/15Anti-ptk7 antibody-drug conjugates
10/29/15Muteins of clotting factor vlll
10/29/15Heteroaromatic compounds and their use as dopamine d1 ligands
10/29/15Heteroaromatic compounds and their use as dopamine d1 ligands
10/29/15Cytotoxic peptides and antibody drug conjugates thereof
10/15/15Bruton's tyrosine kinase inhibitors
10/15/15Dihydropyrrolopyrimidine derivatives
10/15/152-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
10/15/15Heteroaromatic compounds and their use as dopamine d1 ligands
10/15/15Compositions and methods relating to a mutant clostridium difficile toxin
10/15/15Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
10/15/15Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
10/08/15Bicyclic-fused heteroaryl or aryl compounds
10/01/15Use of a tetrasubstituted pyrazolo[4, 3-d]pyrimidine compound for treating diabetic nephropathy
10/01/15Process for annealing amorphous atorvastatin
10/01/15Novel chromene and 1,1a,2,7b-tetrahydrocyclopropa[c]chromene pyridopyrazinediones
10/01/15Use of a tetrasubstituted pyrazolo[4, 3-d]pyrimidine compound for treating diabetic nephropathy
09/24/15Glucagon receptor modulators
09/24/15Glucagon receptor modulators
09/24/15Anti-il-13 receptor alpha 2 antibodies and antibody-drug conjugates
09/24/15Antibodies with ph dependent antigen binding
09/17/15Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
09/17/15Diacylglycerol acyltransferase 2 inhibitors
09/10/15Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
09/03/15Prostate-associated antigens and vaccine-based immunotherapy regimens
09/03/15Pyrrolo[2,3-d]pyrimidine derivatives
08/27/15Salts and polymorphs of 8-fluoro-2--1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
08/27/15Benzamide and heterobenzamide compounds
08/27/15Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
08/20/153-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
08/20/15Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
08/13/15Apixaban solution formulations
08/13/15Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
08/13/15Pyrrolo[2,3-d]pyrimidine derivatives
08/06/15Glycoconjugation processes and compositions
08/06/15Binding molecules to the human ox40 receptor
07/30/15Bifunctional cytotoxic agents
07/23/15Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
07/23/15Pyrrolopyrimidine and purine derivatives
07/23/15Antibodies to il-6 and their uses
07/16/15Heteroaromatic compounds and their use as dopamine d1 ligands
07/09/15Compositions and methods for treatment of abnormal cell growth
07/02/15N-link hydroxamic acid derivatives useful as antibacterial agents
07/02/15Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins
06/25/15Pre moistened wipes for use in treating anal rectal irritations and disorders
06/25/15Aryl and heteroaryl fused lactams
06/25/15Heteroaromatic compounds and their use as dopamine d1 ligands
06/25/15Tricyclic compounds as kat ii inhibitors
06/25/15Circulating tumor cell assay
06/18/15Site-specific integration
06/11/15Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyr-rolo[2,3-d]pyridinyl acrylamides
06/04/15N1/n2-lactam acetyl-coa carboxylase inhibitors
05/28/15Monobactams
05/28/15Monobactams
05/21/15Purine derivatives
05/14/15Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereof
05/14/15Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
05/07/15Vectors for expression of prostate-associated antigens
05/07/15Anti-efna4 antibody-drug conjugates
04/30/15Use of ghrelin receptor inverse agonists or antagonists for treating sleep disorders
04/23/15Substituted acetyl-coa carboxylase inhibitors
04/16/15Human monoclonal antibodies to ctla-4
04/09/15Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
04/09/15Antagonists of prostaglandin ep3 receptor
04/09/15Quinolinyl glucagon receptor modulators
04/02/15Glucagon receptor modulators
03/26/15Diacylglycerol acyltransferase 2 inhibitors
03/26/15Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
03/19/15Triazine derivatives
03/12/15Neisseria meningitidis compositions and methods thereof
03/12/15Novel pyrido[1,2-a]pryazines and their use in the treatment of neurodegenerative and neurological disorders
03/05/15Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
03/05/15Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
03/05/15Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
03/05/15Processes for the preparation of isothiazole derivatives
02/05/15Anti-cxcr4 antibodies and antibody-drug conjugates
02/05/15Indole and indazole compounds that activate ampk
01/29/15Processes for preparing peptide conjugates and linkers
01/29/15Solid forms of a transthyretin dissociation inhibitor
01/22/15N1/n2-lactam acetyl-coa carboxylase inhibitors
01/15/15Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject
01/08/15N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
01/08/15Celecoxib compositions
01/01/15Heteroaromatic compounds and their use as dopamine d1 ligands







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Pfizer Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pfizer Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';